Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

February 2013 - FRMC

Department

Conference Insider
Systemic Lupus Erythematosus in a Managed Care Setting
02/14/2013
Washington, DC—Patients with newly diagnosed and existing systemic lupus erythematosus (SLE) incur high costs and resource use compared with healthy individuals, and the costs increase in patients with SLE-related conditions such as central...
Washington, DC—Patients with newly diagnosed and existing systemic lupus erythematosus (SLE) incur high costs and resource use compared with healthy individuals, and the costs increase in patients with SLE-related conditions such as central...
Washington, DC—Patients with...
02/14/2013
First Report Managed Care
Conference Insider
Costs of DMARDs and Methotrexate for Psoriatic Arthritis
02/14/2013
Washington, DC—Retrospective data from a study conducted to describe healthcare costs associated with the management of psoriatic arthritis (PsA) in patients newly initiated on a biologic therapy or methotrexate (MTX) found that the average...
Washington, DC—Retrospective data from a study conducted to describe healthcare costs associated with the management of psoriatic arthritis (PsA) in patients newly initiated on a biologic therapy or methotrexate (MTX) found that the average...
Washington, DC—Retrospective...
02/14/2013
First Report Managed Care
Conference Insider
Lifetime Risk of Knee Osteoarthritis
02/14/2013
Washington, DC—Black females are at the greatest lifetime risk of being diagnosed with and needing a total knee replacement (TKR) for knee osteoarthritis (OA), investigators reported in a study presented at the ACR meeting that looked at race...
Washington, DC—Black females are at the greatest lifetime risk of being diagnosed with and needing a total knee replacement (TKR) for knee osteoarthritis (OA), investigators reported in a study presented at the ACR meeting that looked at race...
Washington, DC—Black females are...
02/14/2013
First Report Managed Care
Depression and Mortality Associated with Rheumatoid Arthritis
02/14/2013
Washington, DC—Identifying and managing depression in people with rheumatoid arthritis (RA), particularly men, is important based on the results of a study showing an increase in all-cause mortality associated with depression in RA...
Washington, DC—Identifying and managing depression in people with rheumatoid arthritis (RA), particularly men, is important based on the results of a study showing an increase in all-cause mortality associated with depression in RA...
Washington, DC—Identifying and...
02/14/2013
First Report Managed Care
Updated Phase 3 Results of Tofacitinib Therapy Trial
02/14/2013
Washington, DC—After 2 years of treatment with tofacitinib in combination with methotrexate (MTX), patients with active rheumatoid arthritis (RA) with prior inadequate response to MTX showed reduction in progression of structural damage as...
Washington, DC—After 2 years of treatment with tofacitinib in combination with methotrexate (MTX), patients with active rheumatoid arthritis (RA) with prior inadequate response to MTX showed reduction in progression of structural damage as...
Washington, DC—After 2 years of...
02/14/2013
First Report Managed Care
Managing Remission Using TNF Inhibitors or Maintenance Therapy
02/14/2013
Washington, DC—For some patients with rheumatoid arthritis (RA) in clinical remission, tapering the dose of tumor necrosis factor (TNF) inhibitors used for maintenance therapy or extending the time between doses can be done without...
Washington, DC—For some patients with rheumatoid arthritis (RA) in clinical remission, tapering the dose of tumor necrosis factor (TNF) inhibitors used for maintenance therapy or extending the time between doses can be done without...
Washington, DC—For some patients...
02/14/2013
First Report Managed Care
Glucocorticoids in Older and Poorer Patients
02/14/2013
Washington, DC—Despite current guidelines that recommend the use of disease-modifying antirheumatic drugs (DMARDs) for treatment of active rheumatoid arthritis (RA), many people are still treated with glucocorticoids alone for long periods of...
Washington, DC—Despite current guidelines that recommend the use of disease-modifying antirheumatic drugs (DMARDs) for treatment of active rheumatoid arthritis (RA), many people are still treated with glucocorticoids alone for long periods of...
Washington, DC—Despite current...
02/14/2013
First Report Managed Care
DMARDs to Treat Medicare Beneficiaries with Rheumatoid Arthritis
02/14/2013
Washington, DC—Results of a recent study suggest that the choice of biologic disease-modifying antirheumatic drugs (DMARDs) for patients with rheumatoid arthritis (RA) who receive care through Medicare may be influenced by subsidy status...
Washington, DC—Results of a recent study suggest that the choice of biologic disease-modifying antirheumatic drugs (DMARDs) for patients with rheumatoid arthritis (RA) who receive care through Medicare may be influenced by subsidy status...
Washington, DC—Results of a...
02/14/2013
First Report Managed Care
Biologic Agents and Mortality Risk in Rheumatoid Arthritis
02/14/2013
Washington, DC—Treatment of rheumatoid arthritis (RA) with biologic agents is associated with a significant reduction in mortality, Canadian researchers reported in a population-based cohort study presented at the ACR meeting. Although the...
Washington, DC—Treatment of rheumatoid arthritis (RA) with biologic agents is associated with a significant reduction in mortality, Canadian researchers reported in a population-based cohort study presented at the ACR meeting. Although the...
Washington, DC—Treatment of...
02/14/2013
First Report Managed Care
Anti-TNF Drugs to Treat Rheumatoid Arthritis
02/14/2013
Washington, DC—For patients with rheumatoid arthritis (RA), treatment with anti-tumor necrosis factor (anti-TNF) drugs may reduce the need for hip or knee surgeries as well as the need for hospital admissions. Despite the higher costs of...
Washington, DC—For patients with rheumatoid arthritis (RA), treatment with anti-tumor necrosis factor (anti-TNF) drugs may reduce the need for hip or knee surgeries as well as the need for hospital admissions. Despite the higher costs of...
Washington, DC—For patients with...
02/14/2013
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

News
Methotrexate Monotherapy vs Combination Therapy to Lower CV Risk in Early RA?
08/17/2016
As part of the TEAR trial, researchers studied the impact of methotrexate monotherapy or combination therapy with hydroxychloroquine plus sulfasalazine or in combination with etanercept on improving high-density lipoprotein (HDL) cholesterol...
As part of the TEAR trial, researchers studied the impact of methotrexate monotherapy or combination therapy with hydroxychloroquine plus sulfasalazine or in combination with etanercept on improving high-density lipoprotein (HDL) cholesterol...
As part of the TEAR trial,...
08/17/2016
First Report Managed Care
News
Medical Coding Creates Barriers to Care for Transgender Patients
09/13/2022
Many transgender patients in the United States are receiving coverage denials on gender-affirming care due in part to ICD-10 codes.
Many transgender patients in the United States are receiving coverage denials on gender-affirming care due in part to ICD-10 codes.
Many transgender patients in the...
09/13/2022
First Report Managed Care
Bilateral CI Shows Positive Effect on Language
03/16/2012
Results of a study on the effect of cochlear implantation (CI) on language development found that bilateral implantation was more advantageous than unilateral implantation in pediatric patients, according to findings reported in the Archives...
Results of a study on the effect of cochlear implantation (CI) on language development found that bilateral implantation was more advantageous than unilateral implantation in pediatric patients, according to findings reported in the Archives...
Results of a study on the effect...
03/16/2012
First Report Managed Care
News
U.S. Health Care System Unprepared for Major Nuclear Emergency
04/08/2011
04/08/2011
First Report Managed Care
News
In Poll, Obama Is Given Trust Over Medicare
08/23/2012
08/23/2012
First Report Managed Care

Video Insights

Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

February 2013 Volume 10 Issue 2

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement